Ranbaxy's US arm has launched an authorised generic version of Pfizer's fixed-dose combination of atorvastatin-amlodipine besylate, Caduet, in the US, as part of an agreement between the two companies.
Ranbaxy said that it is making available the full range of the generic version of Caduet and that the launch...